Double Therapy of Tenofovir and Telbivudine for Elimination of Virus in Patients With Chronic Hepatitis B Virus Infection Awaiting Assisted Reproduction

Trial Profile

Double Therapy of Tenofovir and Telbivudine for Elimination of Virus in Patients With Chronic Hepatitis B Virus Infection Awaiting Assisted Reproduction

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs Telbivudine (Primary) ; Tenofovir (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms tetecait-hbv
  • Most Recent Events

    • 14 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 29 Jul 2016 Planned number of patients changed from 90 to 120.
    • 29 Jul 2016 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top